Burgess Introduces Drug Pricing Transparency Resolution
Washington,
August 8, 2019
Washington, D.C. —Congressman Michael C. Burgess, M.D. (R-TX), Republican Leader of the Energy and Commerce Subcommittee on Health, recently introduced H.Con.Res. 55, which emphasizes the need to provide American consumers with pricing information in direct-to-consumer (DTC) television advertisements for prescription drugs. “American patients should be informed consumers,” said Dr. Burgess. “Direct-to-consumer advertisements can provide an opportunity for Americans to understand the true cost of their prescription drugs. The Trump Administration has taken steps to make drug pricing information available in DTC advertisements. I am committed to working alongside President Trump to ensure continued transparency in these advertisements, which are prevalent in Americans’ everyday television consumption.” Background: ### |
Latest from twitter
Get the most up to date news from me on Twitter.